Effect of Repeated Administration of Liraglutide on Insulinogenic Indices

Trial Profile

Effect of Repeated Administration of Liraglutide on Insulinogenic Indices

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Mar 2017 Results published in the Journal of Clinical Endocrinology and Metabolism
    • 31 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 01 Jul 2014 New source identified and integrated the European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top